Phosphoproteomic signatures for early detection and stratification of AML

Scott Davis

Exposures from Chernobyl

Leukaemia

Pediatric oncology or childhood cancer Radiation Oncology

Carl E Allen

Redefining Langerhans Cell Histiocytosis as a Myeloid Dysplasia and Identifying Biomarkers for Early Detection and Risk Assessment

Leukaemia

Targeting BCL6 in Tyrosine Kinase-Driven Leukemia

Leukaemia

Hematology and hematologic malignancies Pathology

Global Noncommunicable Diseases Intiatives

Technology transfer for the genetical analysis of hematological neoplasms

Leukaemia

James J-D Hsieh

Molecular Mechanisms of Impaired DAN Damage Response in Leukemia Pathogenesis

Leukaemia

Pathology

Investigator from Ghent University

Dynamic interplay between DNA methylation, histone modifications and super enhancer activity in normal T cells and during malignant T cell transformation

Leukaemia

Bruce R Blazar

Cytotoxic-T-Lymphocyte (CTL) Therapy of Acute Myeloid Leukemia (AML)

Leukaemia

Hematology and hematologic malignancies Pathology

Roland B Walter

Prediction of Treatment-Related Mortality and Therapeutic Resistance in AML

Leukaemia

Hematology and hematologic malignancies Pathology

Lixin Wan

A Novel Oncogenic Role for Cdc20 Implications in Adult T Cell Leukemia Treatment

Leukaemia